Our Institutional Experience with Establishing a PSMA-Targeted Radioligand Therapy Service at Vanderbilt University Medical Center

被引：0
|
作者：
Ali, Hamideh Ale
Harris, DeAngelo [1 ]
Bradshaw, Marques [1 ]
Scherer, Philip [2 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Nashville, TN USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1399
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PSMA-targeted radioligand therapy in prostate cancer
    Heck, M. M.
    Retz, M.
    Tauber, R.
    Knorr, K.
    Kratochwil, C.
    Eiber, M.
    UROLOGE, 2017, 56 (01): : 32 - 39
  • [2] From NETTER to PETTER: PSMA-Targeted Radioligand Therapy
    Eiber, Matthias
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) : 9 - 10
  • [3] PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
    Jones, Wallace
    Griffiths, Kelly
    Barata, Pedro C.
    Paller, Channing J.
    CANCERS, 2020, 12 (06)
  • [4] Heterogeneous tumor PSMA expression represents a resistance mechanism to PSMA-targeted radioligand therapy
    Lueckerath, Katharina
    Current, Kyle
    Meyer, Catherine
    Magyar, Clara
    Mona, Christine E.
    Almajano, Joel
    Slavik, Roger
    Stuparu, Andreea D.
    Cheng, Chloe
    Dawson, David
    Radu, Caius
    Czernin, Johannes
    CANCER RESEARCH, 2020, 80 (16)
  • [5] A systematic review on the current status of PSMA-targeted imaging and radioligand therapy
    Capasso, Giuseppe
    Stefanucci, Azzurra
    Tolomeo, Anna
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 263
  • [6] Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity
    Current, Kyle
    Meyer, Catherine
    Magyar, Clara E.
    Mona, Christine E.
    Almajano, Joel
    Slavik, Roger
    Stuparu, Andreea D.
    Cheng, Chloe
    Dawson, David W.
    Radu, Caius G.
    Czernin, Johannes
    Lueckerath, Katharina
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 2946 - 2955
  • [7] PSMA-targeted radioligand therapy in prostate cancer: current status and future prospects
    Parghane, Rahul, V
    Basu, Sandip
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (09) : 959 - 975
  • [8] Value proposition of PSMA-targeted α–particle radioligand therapy in metastatic prostate cancer
    Hossein Jadvar
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 8 - 10
  • [9] Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer
    Jadvar, Hossein
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (01) : 8 - 10
  • [10] Current Status of PSMA-Targeted Radioligand Therapy in the Era of Radiopharmaceutical Therapy Acquiring Marketing Authorization
    So Won Oh
    Minseok Suh
    Gi Jeong Cheon
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 263 - 281
12345